Wall Street gets another reason to like Eli Lilly stock, and DuPont's spin is going to plan

U.S. markets saw a downturn, with the S&P 500 falling over 1% and the Nasdaq nearly 2% due to tech valuation concerns, though the S&P 500 remains within 1.5% of its record high. Eli Lilly shares bucked the trend, rising on reports of a potential GLP-1 drug pricing deal with the Trump administration, which could involve reduced prices for lower doses in exchange for Medicare/Medicaid obesity coverage. Meanwhile, the DuPont separation is showing promising early results, with the combined value of new DuPont and Qnity Electronics up approximately 8% from its pre-spin price of $81.65, validating the sum-of-the-parts thesis. Investors are also preparing for key AI earnings reports from companies like AMD and Super Micro Computer, alongside Wednesday's October ADP employment report, which is projected to show a gain of 37,500 private jobs.

Analysis

U.S. equity markets experienced a downturn, with the S&P 500 falling over 1% and the Nasdaq nearly 2%, driven by concerns over tech stock valuations after a significant run. Despite this decline, the S&P 500 remains resilient, trading only about 1.5% below its recent record closing high. Eli Lilly (LLY) shares notably outperformed the broader market, rising modestly on reports of a potential GLP-1 drug pricing agreement with the Trump administration.

The proposed LLY deal involves reduced prices for lower GLP-1 drug doses in exchange for Medicare and Medicaid obesity coverage, leveraging Lilly's significant commitment to boosting its U.S. manufacturing footprint. Concurrently, the DuPont (DD) separation is demonstrating promising early success, with both new DuPont and spinoff Qnity Electronics posting positive sessions. The combined entity's value is approximately $88 per share, an 8% increase from DuPont's pre-spin price of $81.65, validating the sum-of-the-parts thesis.

Investors are anticipating a busy earnings period, particularly for AI-related companies such as Advanced Micro Devices (AMD) and Super Micro Computer (SMCI) reporting tonight. Additionally, the October ADP employment report, expected Wednesday, will provide crucial economic insight. Consensus estimates project a gain of 37,500 private jobs, a significant improvement from September's 32,000 decline, offering a potential positive economic signal.

Key Decisions for Investors

• Monitor market volatility and tech sector valuations, while noting the S&P 500's resilience near record highs.
• Evaluate Eli Lilly's (LLY) potential GLP-1 drug pricing deal for its impact on future revenue streams and market access, given the positive market reaction.
• Assess the successful value unlock from the DuPont (DD) separation, as the 8% combined value increase validates the sum-of-the-parts thesis.
• Anticipate market movements driven by upcoming AI earnings reports and the October ADP employment data, which could signal economic recovery.